- Home
- OPRT vs AQST Comparison
OPRT vs AQST Comparison
Compare OPRT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRT
- AQST
- Stock Information
- Founded
- OPRT 2005
- AQST 2004
- Country
- OPRT United States
- AQST United States
- Employees
- OPRT N/A
- AQST N/A
- Industry
- OPRT Finance: Consumer Services
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- OPRT Finance
- AQST Health Care
- Exchange
- OPRT Nasdaq
- AQST Nasdaq
- Market Cap
- OPRT 298.8M
- AQST 272.9M
- IPO Year
- OPRT 2019
- AQST 2018
- Fundamental
- Price
- OPRT $6.78
- AQST $4.07
- Analyst Decision
- OPRT Hold
- AQST Strong Buy
- Analyst Count
- OPRT 2
- AQST 7
- Target Price
- OPRT $8.00
- AQST $11.29
- AVG Volume (30 Days)
- OPRT 804.8K
- AQST 1.3M
- Earning Date
- OPRT 08-07-2025
- AQST 08-05-2025
- Dividend Yield
- OPRT N/A
- AQST N/A
- EPS Growth
- OPRT N/A
- AQST N/A
- EPS
- OPRT N/A
- AQST N/A
- Revenue
- OPRT $746,101,000.00
- AQST $54,228,000.00
- Revenue This Year
- OPRT $28.61
- AQST N/A
- Revenue Next Year
- OPRT $7.22
- AQST $45.71
- P/E Ratio
- OPRT N/A
- AQST N/A
- Revenue Growth
- OPRT N/A
- AQST 5.29
- 52 Week Low
- OPRT $2.37
- AQST $2.12
- 52 Week High
- OPRT $9.25
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- OPRT 48.05
- AQST 72.86
- Support Level
- OPRT $6.88
- AQST $3.62
- Resistance Level
- OPRT $7.26
- AQST $3.80
- Average True Range (ATR)
- OPRT 0.52
- AQST 0.19
- MACD
- OPRT -0.05
- AQST 0.05
- Stochastic Oscillator
- OPRT 27.96
- AQST 95.43
About OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.